US Caprolactam Prices Rise 0.83% Amid Benzene Surge and Supply Disruptions

Caprolactam prices in the United States edged 0.83% higher on a week-on-week basis during the week ending 17 April 2026, registering a modest but meaningful advance against a complex feedstock backdrop. The limited price gain reflects a partial transmission of sharply elevated upstream benzene costs into caprolactam production economics, buffered by the stability of cyclohexanone — the more proximate feedstock — and tempered by cautious downstream market sentiment tied to evolving Middle East geopolitical conditions.

The principal supply-side development during the reference week was a pronounced 12% week-on-week surge in U.S. Gulf Coast benzene values, driven by a tightening of aromatic feedstock availability linked to sustained disruptions in Persian Gulf petrochemical trade flows and its impact on Strait of Hormuz transit. Despite the sharp benzene advance, cyclohexanone values remained stable during the reference period, reflecting adequate intermediate inventory positions at caprolactam producers and partially insulating final product pricing from the full extent of upstream cost inflation. Consequently, the net transmission of cost pressure into caprolactam offers was moderated, yielding a measured rather than commensurate price increase. While Iran announced on 17 April that the Strait of Hormuz was open to commercial vessels following the fragile Israel-Lebanon ceasefire, the U.S. naval blockade of Iranian ports remained fully operative, with shipping companies maintaining caution and only a handful of vessels transiting the waterway — limiting any immediate relief to aromatic feedstock import flows and sustaining the elevated benzene cost environment.

Demand conditions for caprolactam across downstream channels remained stable-to-firm during the reference week, underpinned by consistent nylon 6 resin procurement for engineering polymer and textile fibre applications. The nylon 6 compounding sector maintained steady offtake levels in line with underlying production schedules, with no material deterioration in order book activity reported. The tentative diplomatic signals emanating from the Lebanon ceasefire and initial Strait of Hormuz reopening announcement introduced a degree of wait-and-see behaviour among a subset of caprolactam buyers, who moderated forward-buying activity in anticipation of possible feedstock cost easing. However, this restrained procurement posture was counterbalanced by continued cautionary stocking from caprolactam buyers who remained sceptical of a durable diplomatic resolution, given the persistence of the U.S. naval blockade and Iran's subsequent reassertion of Hormuz control following Washington's refusal to lift the blockade. Overall transacted volumes were stable, with no evidence of demand destruction or material inventory build-up among downstream processors.

The near-term outlook for U.S. caprolactam remains cautiously firm, with price direction largely tied to benzene contract trends in the U.S. Gulf Coast and the status of Strait of Hormuz shipping routes amid ongoing U.S.-Iran negotiations. Persistently high benzene costs are expected to keep caprolactam production economics elevated, sustaining upward pressure despite some cost relief from cyclohexanone. However, any meaningful diplomatic progress could ease feedstock prices and support market stabilization toward late April. Participants should closely track April benzene settlements and developments in regional shipping conditions, as these will act as key indicators shaping caprolactam pricing trends through the second quarter of 2026.